The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer—particularly those with specific HER2 ...
INDIANAPOLIS, Ind. (Ivanhoe Newswire) - Lung cancer is the leading cause of cancer deaths in the U.S., according to the American Cancer Society. For people battling a certain type of lung cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback